Avomeen Analytical Services has been named to the 2015 Inc. 500|5000, a ranking held by the nation’s fastest-growing private companies.

The Inc. 500|5000 list is a well-respected benchmark for the nation’s most successful and innovative organizations. This is Avomeen’s first appearance on the list, yet it achieved a rank of 673rd due to its 670% growth rate over the past three years.

“It is an honor to be named to Inc.’s 500|5000 list and to be identified as one of the upcoming young companies to watch out for over the next few years,” said Shri Thanedar, Avomeen’s chief executive officer and chief chemist. “Avomeen has continued to grow and evolve within the analytical laboratory industry and our impressive growth is attributed to the major expansions made into our product development and advanced pharmaceutical R&D branches.”

Avomeen also received other notable 2015 INC. 500|5000 honors including being ranked in 10th place out of all Michigan companies evaluated. The company is also FDA-registered, DEA-licensed, GMP/GLP-compliant, RoHS/REACH compliant, and ISO 17025-accredited.

“The story of this year’s Inc. 5000 is the story of great leadership. In an incredibly competitive business landscape, it takes something extraordinary to take your company to the top,” said Inc. president and editor-in-chief Eric Schurenberg. “You have to remember that the average company on the Inc. 5000 grew nearly six-fold since 2012. Business owners don’t achieve that kind of success by accident.”

Avomeen’s full service laboratory provides product analysis and development support for a wide range of commercial and industrial industries, but is best known for its advanced analytical testing, customized product development, pharmaceutical R&D and CTM, deformulation and reformulation, manufacturing problem solving, and litigation support services.